The international respiratory community gathered together to share the latest scientific data & findings on respiratory medicine at the ERS congress in September. Below you can find information on Orion Pharma's events during the congress. Please sign-up if you wish to receive access to the recordings and symposium review article. We will send you an e-mail with instructions later this fall. Please notice that this content is available only for healthcare professionals.
Professor Tari Haahtela, Professor Federico Lavorini and Professor Lauri Lehtimäki presented valuable aspects of respiratory therapy for asthma and COPD patients.
Inhaler carbon footprint and sustainability, Professor Tari Haahtela, Skin and Allergy Hospital, University of Helsinki, Finland
Digital solutions in asthma and COPD care, Professor Lauri Lehtimäki, Tampere University Hospital, Finland
Do not fear resistance, Professor Federico Lavorini, Dept. Experimental and Clinical Medicine, Careggi University Hospital Florence, Italy
Orion Pharma and Menarini organised together a virtual symposium on Monday 7th of September. Sign-up below to receive recordings and symposium review article.
Introduction, Professor Eric Bateman
Why do some patients with COPD benefit from inhaled corticosteroid treatment? Professor Klaus Rabe
Key features of inhaler-device technology – what to consider and how to make it work for the patients? Professor Lauri Lehtimäki
Trainers and Trainees: how to ensure successful inhalation therapy for patients? Professor Omar Usmani
Changing perceptions and improving asthma outcomes: spotlight on MART, Professor Eric Bateman
Meeting summary & close
See detailed scientific program here
Please sign up below if you wish to receive news regarding the symposium, booth presentations or get access to the recordings afterwards. You will also get access to the symposium review article. Please notice that this content is available only for healthcare professionals.
To receive further information on how we process your personal data, please read more here. You may withdraw your consent at any time by clicking the link in any of the communications you receive. Please note that withdrawal of your consent will not render the processing of your information prior to the withdrawal unlawful.
ERS declines all responsibility with respect to the information published in this document.